SEAWOLF THERAPEUTICS Trademark

Trademark Overview

On Thursday, October 21, 2021, a trademark application was filed for SEAWOLF THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SEAWOLF THERAPEUTICS trademark a serial number of 97085599. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Thursday, March 19, 2026. This trademark is owned by Seawolf Therapeutics, Inc.. The SEAWOLF THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals

General Information

Serial Number97085599
Word MarkSEAWOLF THERAPEUTICS
Filing DateThursday, October 21, 2021
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateThursday, March 19, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2022

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Pseudo MarkSEA WOLF THERAPEUTICS
Goods and ServicesResearch and development of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, November 7, 2021
Primary Code042
First Use Anywhere DateSunday, June 30, 2024
First Use In Commerce DateSunday, June 30, 2024

Trademark Owner History

Party NameSeawolf Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
US
Party NameSeawolf Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94104
US

Trademark Events

Event DateEvent Description
Monday, October 25, 2021NEW APPLICATION ENTERED
Sunday, November 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 28, 2022ASSIGNED TO EXAMINER
Thursday, August 4, 2022NON-FINAL ACTION WRITTEN
Thursday, August 4, 2022NON-FINAL ACTION E-MAILED
Thursday, August 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 23, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 23, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, August 23, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 23, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, August 23, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 27, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 27, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 27, 2023SOU EXTENSION 1 FILED
Monday, March 27, 2023SOU EXTENSION 1 GRANTED
Wednesday, March 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 23, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 23, 2023SOU EXTENSION 2 FILED
Monday, October 23, 2023SOU EXTENSION 2 GRANTED
Wednesday, October 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 11, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 11, 2024SOU EXTENSION 3 FILED
Thursday, April 11, 2024SOU EXTENSION 3 GRANTED
Friday, April 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 11, 2024SOU EXTENSION 4 FILED
Wednesday, September 11, 2024SOU EXTENSION 4 GRANTED
Wednesday, September 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 7, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, May 7, 2025SOU EXTENSION 5 FILED
Monday, September 8, 2025SOU EXTENSION 5 GRANTED
Wednesday, September 10, 2025TEAS STATEMENT OF USE RECEIVED
Monday, September 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 18, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 10, 2025USE AMENDMENT FILED
Thursday, March 19, 2026STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

therapeutics seawolf pharmaceuticals development research